|
Myeloproliferative disorders are a group of slow-growing blood cancers, including chronic myelogenous leukemia, in which large numbers of abnormal red blood cells, white blood cells, or platelets grow and spread in the bone marrow and the peripheral blood.
The following PDQ treatment summaries are available:
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
Includes childhood myelodysplastic syndromes and other myeloproliferative
disorders.
[ patients ] [ health
professionals ] |
|
|
Acute Myeloid Leukemia
[ patients ] [ health
professionals ] |
|
|
Chronic Myelogenous Leukemia
[ patients ] [ health
professionals ] |
|
|
Chronic Myeloproliferative Disorders
[ patients ] [ health
professionals ] |
|
|
| |
| Subsections of this summary include: |
- Polycythemia Vera
- Chronic Idiopathic Myelofibrosis
- Essential Thrombocythemia
- Chronic Neutrophilic Leukemia
- Chronic Eosinophilic Leukemia
|
|
|
Myelodysplastic Syndromes
Includes refractory anemia, refractory anemia with excess blasts, refractory
anemia with ringed sideroblasts, refractory cytopenia with multilineage
dysplasia, unclassifiable myelodysplastic syndrome, and myelodysplastic
syndrome associated with del (5q).
[ patients ] [ health
professionals ] |
|
|
| |
| Subsections of this summary include: |
- De novo Myelodysplastic Syndrome
- Secondary Myelodysplastic Syndrome
- Previously Treated Myelodysplastic Syndrome
|
|
|
Myelodysplastic/Myeloproliferative Diseases
[ patients ] [ health
professionals ] |
|
|
| |
| Subsections of this summary include: |
- Chronic Myelomonocytic Leukemia
- Juvenile Myelomonocytic Leukemia
- Atypical Chronic Myeloid Leukemia
- Myelodysplastic/Myeloproliferative Disease, Unclassifiable
|
|
|
Back to Top |
